Nothing Special   »   [go: up one dir, main page]

KR890004726A - 마이코플라즈마 백신 - Google Patents

마이코플라즈마 백신 Download PDF

Info

Publication number
KR890004726A
KR890004726A KR1019880012000A KR880012000A KR890004726A KR 890004726 A KR890004726 A KR 890004726A KR 1019880012000 A KR1019880012000 A KR 1019880012000A KR 880012000 A KR880012000 A KR 880012000A KR 890004726 A KR890004726 A KR 890004726A
Authority
KR
South Korea
Prior art keywords
strain
mycoplasma
vaccine
intervet
poultry
Prior art date
Application number
KR1019880012000A
Other languages
English (en)
Other versions
KR970003054B1 (ko
Inventor
카렐 스토름 폴
Original Assignee
에이.쥐.제이. 베르메렌, 에이.디. 도우마
악조 엔.브이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에이.쥐.제이. 베르메렌, 에이.디. 도우마, 악조 엔.브이 filed Critical 에이.쥐.제이. 베르메렌, 에이.디. 도우마
Publication of KR890004726A publication Critical patent/KR890004726A/ko
Application granted granted Critical
Publication of KR970003054B1 publication Critical patent/KR970003054B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/826—Bacterial vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

내용 없음

Description

마이코플라즈마 백신
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
첨부하는 도면 제1도는 인터베트 6/85 균주의 엔도뉴클레아제 제한 양상이다.

Claims (6)

  1. 인터베트(Intervet) 6/85 균주의 면역학적 특성들을 갖는 마이코플라즈마 갈리셉티쿰 (Mycoplasma gallisepticum)으로부터 유래된 백신임을 특징으로 하는 가금류에 있어서의 마이코플라즈마 감연 억제용 백신.
  2. 제1항에 있어서, 인터베트 6/85 균주의 면역학적 특성들을 갖는 살아 있는 마이코플라즈마 갈리셉티쿰 균주를 함유함을 특징으로 하는 백신.
  3. 제1항 또는 제2항에 있어서, 상기 백신이 인터베트 6/85 균주로부터 유래된 것임을 특징으로 하는 백신.
  4. 인터베트 6/85 균주의 면역학적 특성들을 갖는 마이코플라즈마 갈리셉티쿰 균주.
  5. 인터베트 6/85 마이코플라즈마 갈리셉티쿰 균주.
  6. 제1항 또는 제3항 중 어느 한항에 따른 백신을 가금류에 투여함을 특징으로 하는 가금류에 있어서의 마이코플라즈마 감염 억제방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880012000A 1987-09-18 1988-09-16 마이코플라즈마 백신 KR970003054B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8702232 1987-09-18
NL87.02232 1987-09-18

Publications (2)

Publication Number Publication Date
KR890004726A true KR890004726A (ko) 1989-05-09
KR970003054B1 KR970003054B1 (ko) 1997-03-14

Family

ID=19850632

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880012000A KR970003054B1 (ko) 1987-09-18 1988-09-16 마이코플라즈마 백신

Country Status (18)

Country Link
US (1) US5064647A (ko)
EP (1) EP0307976B1 (ko)
JP (1) JP2718518B2 (ko)
KR (1) KR970003054B1 (ko)
AR (1) AR242339A1 (ko)
AU (1) AU608058B2 (ko)
CA (1) CA1336262C (ko)
DD (1) DD282393A5 (ko)
DE (1) DE3881993T2 (ko)
DK (1) DK175065B1 (ko)
ES (1) ES2058237T3 (ko)
HU (1) HU203841B (ko)
IE (1) IE61398B1 (ko)
IL (1) IL87359A (ko)
NZ (1) NZ226208A (ko)
PT (1) PT88524B (ko)
YU (1) YU46552B (ko)
ZA (1) ZA885707B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215914A (en) * 1986-06-18 1993-06-01 American Registry Of Pathology Adherent and invasive mycoplasma
CA1339260C (en) * 1988-06-02 1997-08-12 Kazumi Kodama Poultry mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
USRE39494E1 (en) * 1992-02-27 2007-02-27 Intervet Inc. Inactivated mycoplasma hyopneumoniae and uses therefor
ZA9710606B (en) * 1996-12-05 1998-06-12 Akzo Nobel Nv Non-virulent Mycoplasma synoviae vaccine thereof.
EP0846468B1 (en) * 1996-12-05 2004-06-09 Akzo Nobel N.V. Non-virulent mycoplasma synoviae and vaccine thereof
US20040208842A1 (en) * 2001-09-18 2004-10-21 Ritchie Branson W. Antimicrobial cleansing compositions and methods of use
US20040151765A1 (en) * 2001-09-18 2004-08-05 Ritchie Branson W. Methods and compositions for wound management
US20070003508A1 (en) 2005-07-01 2007-01-04 Wooley Richard E Methods and compositions for promoting wound healing
BR0210804A (pt) 2001-07-02 2005-05-03 Pfizer Prod Inc Vacinação de dose única com mycoplásma hyopneumoniae
US7217420B2 (en) * 2002-07-13 2007-05-15 The University Of Georgia Research Foundation, Inc. Mycoplasma gallisepticum formulation
US20070185202A1 (en) * 2004-03-03 2007-08-09 University Of Georgia Research Foundation, Inc. Methods and compositions for ophthalmic treatment of fungal and bacterial infections
US20090068231A1 (en) * 2007-09-11 2009-03-12 Wyeth Live attenuated mycoplasma strains
TW200918666A (en) * 2007-09-11 2009-05-01 Wyeth Corp Attenuated mycoplasma gallisepticum strains

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534136A (en) * 1969-09-19 1970-10-13 Research Corp M.g. inoculum for poultry
JPS5540568B2 (ko) * 1972-10-05 1980-10-18
JPS52134019A (en) * 1976-04-28 1977-11-09 Biseibutsu Kagaku Kenkiyuushiy Micoplasma galicepticum infection vaccine

Also Published As

Publication number Publication date
EP0307976A1 (en) 1989-03-22
YU173588A (en) 1990-02-28
AU2233488A (en) 1989-03-23
IE61398B1 (en) 1994-11-02
PT88524B (pt) 1992-11-30
IE882361L (en) 1989-03-18
YU46552B (sh) 1993-11-16
DK520088A (da) 1989-03-19
PT88524A (pt) 1988-10-01
AU608058B2 (en) 1991-03-21
ES2058237T3 (es) 1994-11-01
US5064647A (en) 1991-11-12
CA1336262C (en) 1995-07-11
DK175065B1 (da) 2004-05-17
HUT47866A (en) 1989-04-28
KR970003054B1 (ko) 1997-03-14
DE3881993D1 (en) 1993-07-29
EP0307976B1 (en) 1993-06-23
IL87359A (en) 1992-11-15
DD282393A5 (de) 1990-09-12
JP2718518B2 (ja) 1998-02-25
DK520088D0 (da) 1988-09-16
NZ226208A (en) 1991-02-26
IL87359A0 (en) 1989-01-31
DE3881993T2 (de) 1993-09-30
ZA885707B (en) 1989-04-26
JPH01131123A (ja) 1989-05-24
AR242339A1 (es) 1993-03-31
HU203841B (en) 1991-10-28

Similar Documents

Publication Publication Date Title
KR890004726A (ko) 마이코플라즈마 백신
KR830000679A (ko) N-알킬화 아미노알콜의 제조방법
DE3784501D1 (de) Wasserabweisendes mittel fuer bauwerke.
KR830003529A (ko) 플라스틱 식기
KR870011182A (ko) 합성 수지용 개질제
KR830004215A (ko) 환상 펩티드핵
KR880013608A (ko) 유화조성물
DK0529019T3 (da) Nematodevaccine
KR920701418A (ko) 효모 추출물의 제조방법
KR840002239A (ko) 화장품
KR870007667A (ko) 떡의 부패 방지법
KR850008492A (ko) 트랜스, 트랜스-8,10-도데카디엔-1-일옥시실란의 제조방법
KR880009053A (ko) 경화성 오르가노폴리실록산
KR910012071A (ko) 폴리에틸렌 테레프탈레이트 수지조성물
KR870007917A (ko) 4-아세틸 이소퀴놀리논 화합물의 제조방법
KR840001144A (ko) 5(6)-페닐설포닐옥시-벤즈이미다졸 유도체의 제조방법
KR880009095A (ko) 자외선 경화성 겔 조성물
KR910012257A (ko) 벤즈안트라센 화합물 및 이의 제조방법
KR920007562A (ko) 효모 엑기스의 제조방법
KR920003993A (ko) 돼지 뇌심근염(emc)바이러스와 파보바이러스 혼합유성백신의 제조방법
KR860003032A (ko) 단군무술(檀君武術)
KR880013490A (ko) 함성수지 갓
KR930013086A (ko) 난백을 이용한 효모 엑스(extract)의 제조방법
KR890017287A (ko) 실리콘 에멀젼의 처리방법
KR840002008A (ko) 중합체의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20110722

Year of fee payment: 15

EXPY Expiration of term